These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9559223

  • 1. Effects of antihypertensive drugs on cholesterol metabolism of human mononuclear leukocytes and hepatoma cells.
    Naegele H, Behnke B, Gebhardt A, Strohbeck M.
    Clin Biochem; 1998 Feb; 31(1):37-45. PubMed ID: 9559223
    [Abstract] [Full Text] [Related]

  • 2. Verapamil enhances high-density lipoprotein processing in Hep G2 cells preloaded with cholesterol.
    Chappey-Gillet B, Salmon S, Mazière C, Auclair M, Mazière JC.
    Biochim Biophys Acta; 1990 May 02; 1052(2):273-7. PubMed ID: 2159347
    [Abstract] [Full Text] [Related]

  • 3. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2.
    Corsini A, Granata A, Fumagalli R, Paoletti R.
    Pharmacol Res Commun; 1986 Jan 02; 18(1):1-16. PubMed ID: 3006091
    [Abstract] [Full Text] [Related]

  • 4. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A, Salvayre R.
    Br J Pharmacol; 1992 Nov 02; 107(3):738-44. PubMed ID: 1472971
    [Abstract] [Full Text] [Related]

  • 5. The antihypertensive drug propranolol enhances LDL catabolism and alters cholesterol metabolism in human cultured fibroblasts.
    Mazière C, Mazière JC, Salmon S, Mora L, Auclair M.
    Atherosclerosis; 1990 Mar 02; 81(2):151-60. PubMed ID: 2322324
    [Abstract] [Full Text] [Related]

  • 6. Effect of verapamil and nifedipine on cholesteryl ester metabolism and low-density lipoprotein oxidation in macrophages.
    Dushkin MI, Schwartz YS.
    Biochem Pharmacol; 1995 Jan 31; 49(3):389-97. PubMed ID: 7857326
    [Abstract] [Full Text] [Related]

  • 7. Effects of various antihypertensive agents on lipid metabolism: alterations in the pattern of lipids synthesized from [14C]oleate in rat liver in vitro.
    Bell FP.
    J Cardiovasc Pharmacol; 1985 Jan 31; 7(3):443-8. PubMed ID: 2410672
    [Abstract] [Full Text] [Related]

  • 8. [Metabolism of cholesterol esters in cultured macrophages under the action of the calcium antagonists verapamil and nifedipine].
    Dushkin MI, Ivanova MV.
    Biokhimiia; 1991 May 31; 56(5):812-9. PubMed ID: 1747410
    [Abstract] [Full Text] [Related]

  • 9. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987 May 31; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 10. Effects of antihypertensive agents propranolol, metoprolol, nadolol, prazosin, and chlorthalidone on ACAT activity in rabbit and rat aortas and on LCAT activity in human plasma in vitro.
    Bell FP.
    J Cardiovasc Pharmacol; 1985 May 31; 7(3):437-42. PubMed ID: 2410671
    [Abstract] [Full Text] [Related]

  • 11. [The effect of verapamil and nifedipine on cholesterol esterification and accumulation in macrophages].
    Dushkin MI, Ivanova MV.
    Eksp Klin Farmakol; 1992 May 31; 55(3):37-9. PubMed ID: 1458160
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of low density lipoprotein receptor activity by tumor necrosis factor, a process independent of tumor necrosis factor-induced lipid synthesis and secretion.
    Liao W, Florén CH.
    Lipids; 1994 Oct 31; 29(10):679-84. PubMed ID: 7861934
    [Abstract] [Full Text] [Related]

  • 13. [Antihypertensive therapy and lipid metabolism].
    Krone W, Müller-Wieland D, Greten H.
    Klin Wochenschr; 1984 Mar 01; 62(5):193-202. PubMed ID: 6143851
    [Abstract] [Full Text] [Related]

  • 14. [The effect of calcium antagonists on cholesterol metabolism in human aortal intima cells and macrophage lines].
    Iakushkin VV, Orekhov AN.
    Biokhimiia; 1992 Nov 01; 57(11):1684-92. PubMed ID: 1283337
    [Abstract] [Full Text] [Related]

  • 15. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
    Kamps JA, van Berkel TJ.
    Eur J Biochem; 1992 Jun 15; 206(3):973-8. PubMed ID: 1318843
    [Abstract] [Full Text] [Related]

  • 16. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Bouscarel B, Ceryak S, Fromm H.
    Biochim Biophys Acta; 1996 Jun 11; 1301(3):230-6. PubMed ID: 8664333
    [Abstract] [Full Text] [Related]

  • 17. Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes.
    Müller-Wieland D, Behnke B, Koopmann K, Krone W.
    Biochem Biophys Res Commun; 1994 Aug 30; 203(1):416-21. PubMed ID: 8074686
    [Abstract] [Full Text] [Related]

  • 18. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
    Azuma Y, Kawasaki T, Ohno K, Seto J, Yamada T, Yamasaki M, Nobuhara Y.
    Jpn J Pharmacol; 1999 Feb 30; 79(2):151-8. PubMed ID: 10202850
    [Abstract] [Full Text] [Related]

  • 19. Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2.
    Semenkovich CF, Ostlund RE.
    Biochemistry; 1987 Aug 11; 26(16):4987-92. PubMed ID: 2822102
    [Abstract] [Full Text] [Related]

  • 20. Effects of adrenergic agonists and antagonists on the metabolism of [1-14C]oleic acid by rat hepatocytes.
    Olubadewo JO, Heimberg M.
    Biochem Pharmacol; 1993 Jun 22; 45(12):2441-7. PubMed ID: 8328982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.